KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Payables: 2009-2024

Historic Payables for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $140.3 million.

  • Charles River Laboratories International's Payables rose 24.75% to $169.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $605.1 million, marking a year-over-year increase of 6.59%. This contributed to the annual value of $140.3 million for FY2024, which is 16.93% down from last year.
  • According to the latest figures from FY2024, Charles River Laboratories International's Payables is $140.3 million, which was down 16.93% from $168.9 million recorded in FY2023.
  • In the past 5 years, Charles River Laboratories International's Payables ranged from a high of $205.9 million in FY2022 and a low of $122.5 million during FY2020.
  • Over the past 3 years, Charles River Laboratories International's median Payables value was $168.9 million (recorded in 2023), while the average stood at $171.7 million.
  • In the last 5 years, Charles River Laboratories International's Payables spiked by 61.77% in 2021 and then declined by 17.96% in 2023.
  • Charles River Laboratories International's Payables (Yearly) stood at $122.5 million in 2020, then spiked by 61.77% to $198.1 million in 2021, then grew by 3.93% to $205.9 million in 2022, then fell by 17.96% to $168.9 million in 2023, then declined by 16.93% to $140.3 million in 2024.